Sandra Carson 
Blastomycosis in Dogs: Symptoms, Causes & Treatment Guide
Blastomycosis in Dogs: Complete Guide for Dog Lovers
Last Updated:
That persistent cough, the mysterious skin lesions, the sudden loss of appetite in your beloved dog—these concerning symptoms could point to blastomycosis, a serious fungal infection that affects both dogs and humans.
In this comprehensive guide, we'll explore everything you need to know about blastomycosis in dogs—from recognizing the varied symptoms and understanding how it spreads to learning about effective treatment options and prevention strategies.
Keep reading to discover how to protect your dog from this potentially fatal fungal infection and what to do if you suspect your canine companion may be affected. Your attention to this guide could save your dog's life.
What is Blastomycosis?
Blastomycosis is a systemic fungal infection caused by the dimorphic fungus Blastomyces dermatitidis. This serious disease primarily affects the respiratory system but can spread to other organs, including the skin, eyes, bones, and nervous system. The fungus exists in the environment in a mold form but transforms into a yeast form when it infects warm-blooded animals.
Did You Know?
Blastomycosis is often called "Blasto" for short and is sometimes referred to as "Chicago disease" due to its prevalence in that region. The fungus was first identified by Thomas Casper Gilchrist in 1894, which is why it's sometimes called Gilchrist's disease. Blastomyces dermatitidis thrives in moist, acidic soil rich in organic matter, particularly in areas near waterways.
Key characteristics of blastomycosis include:
- Systemic Fungal Infection: Can affect multiple organ systems throughout the body
- Environmental Source: Acquired from soil and decaying organic matter
- Dimorphic Fungus: Exists as mold in environment, yeast in infected tissues
- Geographic Distribution: Primarily found in specific regions of North America
- Serious Prognosis: Can be fatal without appropriate treatment
How Blastomyces Affects Dogs
When a dog inhales Blastomyces spores from the environment, the spores transform into yeast forms in the lungs. The yeast cells multiply and can spread through the bloodstream to various organs. This process causes:
- Granulomatous inflammation in affected tissues
- Formation of abscesses and nodules
- Tissue destruction at infection sites
- Immune system activation and inflammatory responses
- Organ dysfunction in severe cases
The severity of infection depends on factors such as the number of spores inhaled, the dog's immune status, and how quickly treatment is initiated. Young, large-breed dogs and sporting breeds appear to be at higher risk, possibly due to increased outdoor exposure.
Symptoms and Clinical Signs of Blastomycosis
Symptoms of blastomycosis can vary significantly between dogs, ranging from mild respiratory signs to severe multi-systemic illness. The clinical presentation depends on factors such as the organs affected, the duration of infection, and the dog's immune response.
Respiratory Symptoms
- Coughing (often dry and harsh)
- Difficulty breathing
- Exercise intolerance
- Rapid breathing
- Nasal discharge
- Wheezing or abnormal lung sounds
Systemic Symptoms
- Fever
- Lethargy and depression
- Loss of appetite
- Weight loss
- Swollen lymph nodes
- Generalized weakness
Other Organ Involvement
- Skin lesions (ulcers, abscesses, draining tracts)
- Eye inflammation or blindness
- Lameness (bone involvement)
- Neurological symptoms (seizures, incoordination)
- Testicular swelling
- Heart rhythm abnormalities
Important Note
Blastomycosis is often called "the great pretender" because its symptoms can mimic many other diseases. Respiratory signs may be mistaken for kennel cough or pneumonia, while skin lesions can be confused with bacterial infections or cancer. The disease typically has an incubation period of 5-12 weeks after exposure, though this can vary. Up to 40% of dogs with blastomycosis may have eye involvement, which can lead to permanent blindness if not treated promptly. Early recognition and treatment are critical for successful outcomes.
Symptom Patterns by Organ System
| Organ System | Common Symptoms | Diagnostic Clues | Prognosis Impact |
|---|---|---|---|
| Respiratory System | Cough, difficulty breathing, exercise intolerance | Radiographic changes, respiratory distress | Better if limited to lungs; worse with severe involvement |
| Skin and Subcutaneous | Ulcers, abscesses, draining tracts, nodules | Visible lesions, cytology or biopsy | Generally better; accessible for diagnosis and monitoring |
| Ocular System | Eye inflammation, cloudiness, blindness, pain | Ophthalmic examination, retinal changes | Guarded; may result in permanent vision loss |
| Nervous System | Seizures, incoordination, behavior changes | Neurological exam, CSF analysis, imaging | Most guarded; indicates severe, disseminated disease |
The progression of blastomycosis can be rapid, with some dogs developing severe respiratory distress within days of symptom onset. Other dogs may have a more chronic presentation with weight loss and gradual decline. The mortality rate without treatment approaches 100%, but with appropriate antifungal therapy, survival rates of 70-75% can be achieved.
Blastomyces Fungus Characteristics
Understanding the unique characteristics of Blastomyces dermatitidis is crucial for understanding transmission, diagnosis, and control strategies.
Blastomyces Fungus Features
Dimorphic Nature
Exists as mold in the environment (producing infectious spores) but transforms into yeast form in infected tissues at body temperature.
Spore Production
Produces microscopic spores (conidia) that become airborne when soil is disturbed. These spores are the infectious form.
Environmental Requirements
Thrives in moist, acidic soil rich in organic matter, particularly near rivers, lakes, and wetlands with decaying vegetation.
Yeast Form Characteristics
In tissues, appears as large, round yeast cells with thick, refractile walls and characteristic broad-based budding.
Key Aspects of Blastomyces Biology
| Characteristic | Environmental Form (Mold) | Tissue Form (Yeast) |
|---|---|---|
| Appearance | White, cottony mold with microscopic conidiophores | Large, round yeast cells (8-15μm) with thick walls |
| Temperature Preference | Grows at 25-30°C (77-86°F) | Grows at 37°C (98.6°F) - body temperature |
| Infective Capability | Produces infectious spores (conidia) | Not directly infectious; reproduces in host tissues |
| Diagnostic Significance | Difficult to culture from environment | Identifiable in tissue samples, cytology, or culture |
Fungus Identification Importance
The dimorphic nature of Blastomyces dermatitidis is crucial for understanding disease transmission and diagnosis. The environmental mold form produces the infectious spores that dogs (and humans) inhale. Once in the lungs, the spores transform into the yeast form, which is not contagious between animals or to humans. This transformation explains why blastomycosis is not directly transmissible between dogs or from dogs to humans - the infectious form exists only in the environment. Identification of the characteristic yeast forms in tissue samples or cytology specimens provides definitive diagnosis, while culture can confirm the identity but takes several weeks and carries biohazard risks.
How Blastomycosis Spreads
Blastomycosis is acquired through environmental exposure rather than direct transmission between animals. Understanding these exposure routes is crucial for effective prevention.
Primary Exposure Routes
1 Inhalation of Spores
Inhalation of microscopic fungal spores (conidia) from contaminated soil or decaying organic matter. This is the only significant route of infection.
2 Soil Disturbance
Activities that disturb contaminated soil release spores into the air. Digging, construction, or even strong winds can aerosolize spores.
3 Environmental Exposure
Spending time in endemic areas, particularly near waterways, wooded areas, or construction sites with exposed soil.
4 Rare Transmission Routes
In rare cases, infection through skin wounds or transplacental transmission. These are uncommon and not significant for disease control.
Geographic Distribution and High-Risk Areas
1 Major Endemic Regions
Ohio and Mississippi River valleys, Great Lakes region, St. Lawrence River valley, and the southeastern United States.
2 Specific High-Risk Environments
Riverbanks, lakeshores, wetlands, wooded areas with moist soil, and areas with decaying organic matter or bird droppings.
3 Seasonal Patterns
Most cases occur in late summer and fall, possibly related to outdoor activities and environmental conditions favorable for spore release.
4 Microenvironments
Even within endemic areas, the fungus exists in "microfoci" - specific localized areas where conditions are ideal for growth.
Important Note
It's crucial to understand that blastomycosis is NOT contagious between animals or from animals to humans. The infectious form exists only in the environment as mold spores. Once an animal or person is infected, the fungus transforms into the yeast form, which is not airborne or contagious. This means that dogs with blastomycosis do not need to be isolated from other pets or family members. However, if one dog in a household develops blastomycosis, other dogs in the same household may have been exposed to the same environmental source and should be monitored closely for symptoms.
High-Risk Environments and Situations
- Waterfront Properties: Homes near rivers, lakes, or streams in endemic areas
- Recent Construction: Soil disturbance from building or excavation projects
- Outdoor Activities: Hunting, hiking, or camping in wooded areas
- Specific Dog Breeds: Large breeds and sporting dogs with more outdoor exposure
- Young Dogs: Dogs under 4 years old appear to be at higher risk
- Male Dogs: Some studies show a slightly higher incidence in males
- Immunocompromised Dogs: Those with weakened immune systems may be more susceptible
Despite these risk factors, any dog with access to endemic environments can potentially develop blastomycosis. The unpredictable distribution of the fungus in the environment makes complete avoidance challenging in endemic areas.
Diagnosis and Testing for Blastomycosis
Accurate and timely diagnosis of blastomycosis is essential for successful treatment. Multiple diagnostic methods are typically used in combination due to the varied presentations of the disease.
Diagnostic Challenges
- Non-Specific Symptoms: Early signs often mimic more common conditions
- Geographic Variation: May not be considered in areas where it's less common
- Testing Limitations: No perfect single test; combination approach often needed
- Sample Collection Issues: May be difficult to obtain appropriate samples
- Slow Culture Growth: Fungal culture takes 2-4 weeks for results
Diagnostic Tests for Blastomycosis
| Test Type | Methodology | Purpose and Accuracy | Advantages/Limitations |
|---|---|---|---|
| Cytology/Histopathology | Microscopic examination of tissue samples or body fluids | Definitive diagnosis when yeast forms are identified | Rapid, specific; requires appropriate sample with organisms |
| Antigen Testing | Detects Blastomyces antigen in urine, serum, or other fluids | Highly sensitive; good for screening and monitoring | Very sensitive; may cross-react with other fungi |
| Antibody Testing | Detects antibodies against Blastomyces | Supports diagnosis; variable sensitivity and specificity | Can indicate exposure; less reliable than antigen testing |
| Fungal Culture | Growing fungus from tissue samples or body fluids | Gold standard; allows species identification | Definitive but slow (2-4 weeks); biohazard risk |
| PCR Testing | Detects fungal DNA in tissue samples | Rapid, specific; useful when organisms are scarce | Highly specific; availability may be limited |
Proper interpretation of blastomycosis test results requires understanding their clinical significance and limitations:
- Cytology/Histopathology: Finding the characteristic broad-based budding yeast forms provides definitive diagnosis. This is often possible from fine needle aspirates of skin lesions, lymph nodes, or lung samples. A negative result doesn't rule out infection if the sample didn't contain affected tissue.
- Antigen Testing: The urine antigen test is highly sensitive (90-95%) and is valuable for both diagnosis and monitoring treatment response. Antigen levels typically decrease with successful treatment. False positives can occur with Histoplasma or other related fungal infections.
- Antibody Testing: Less reliable than antigen testing. A positive result indicates exposure but not necessarily active disease. False negatives are common, especially in early infection or immunocompromised patients.
- Fungal Culture: The gold standard but takes 2-4 weeks. Carries biohazard risk to laboratory personnel. Not practical for rapid diagnosis but useful for confirming unusual cases.
- PCR Testing: Highly specific but not yet widely available. Useful when organisms are scarce in samples.
The most efficient diagnostic approach often involves urine antigen testing combined with cytology of accessible lesions. Imaging studies (radiographs, ultrasound) help determine the extent of disease but are not diagnostic alone.
When to Test for Blastomycosis
Veterinarians typically recommend testing for blastomycosis when:
- Dogs from endemic areas develop respiratory symptoms
- Unexplained skin lesions with draining tracts appear
- Eye inflammation of unknown cause develops
- Dogs have visited endemic areas within the past several months
- Multiple system involvement without clear cause
- Fever of unknown origin in dogs from endemic regions
- Lymph node enlargement with systemic signs
- Lameness with bone lesions on radiographs
Diagnostic Approach Recommendations
The most efficient diagnostic approach for suspected blastomycosis typically begins with urine antigen testing due to its high sensitivity. Concurrently, cytological examination of accessible lesions (skin, lymph nodes, lung aspirates) should be performed. If these are negative but clinical suspicion remains, antibody testing or PCR may be considered. Thoracic radiographs are valuable for assessing pulmonary involvement, which occurs in 65-85% of cases. For monitoring treatment response, serial urine antigen tests are the most useful tool, with levels typically decreasing with successful therapy. The combination of antigen testing and cytology provides diagnosis in the majority of cases, allowing prompt initiation of treatment.
Treatment Options for Blastomycosis
Successful blastomycosis treatment requires prolonged courses of specific antifungal medications, often combined with supportive care. Treatment duration is typically lengthy, often lasting several months.
⚠️ Important Treatment Consideration
Blastomycosis treatment must be completed under strict veterinary supervision. Never discontinue medications prematurely, as this can lead to relapse with potentially drug-resistant organisms. The initial phase of treatment may cause temporary worsening of symptoms as fungi die and release antigens, triggering inflammatory responses. Regular monitoring through physical examinations, laboratory tests, and antigen levels is essential throughout treatment. Some antifungal medications can have serious side effects requiring careful monitoring.
Treatment Approaches
Treatment strategies for blastomycosis involve specific antifungal medications and supportive care:
- Antifungal Medications:
- Itraconazole: The treatment of choice for most cases. Typically given for 60-90 days minimum, often longer. Has good tissue penetration and fewer side effects than amphotericin B.
- Amphotericin B: Reserved for severe cases, especially those with neurological involvement. Administered intravenously, often followed by itraconazole. Requires careful monitoring for kidney toxicity.
- Fluconazole: Less effective than itraconazole but may be used in certain situations, such as when cost is a concern or for urinary tract involvement.
- Voriconazole: Newer azole antifungal sometimes used for refractory cases or when other medications aren't tolerated.
- Supportive Care:
- Oxygen Therapy: For dogs with severe respiratory distress.
- Fluid Therapy: Important for dehydrated patients or those with kidney concerns.
- Nutritional Support: Ensuring adequate nutrition during prolonged illness.
- Pain Management: Appropriate analgesics for dogs with bone pain or other discomfort.
- Anti-inflammatory Medications: Sometimes used cautiously to manage severe inflammatory responses.
- Adjunctive Measures:
- Regular Monitoring: Physical exams, lab work, and antigen testing throughout treatment.
- Treatment of Complications: Addressing specific organ involvement as needed.
- Client Education: Ensuring owners understand the prolonged nature of treatment.
Treatment typically continues for at least 60-90 days, with many cases requiring 4-6 months or longer. Medication should continue for at least 1 month beyond clinical resolution and normalization of laboratory parameters. Most dogs show clinical improvement within 1-2 weeks of starting appropriate treatment, though complete resolution of symptoms and radiographic changes takes longer.
Monitoring and Follow-up Care
Successful blastomycosis management requires careful monitoring throughout treatment and beyond:
- Clinical Assessment: Regular physical examinations to assess improvement in symptoms and identify new issues.
- Urine Antigen Testing: The most valuable monitoring tool. Levels should decrease with successful treatment. Testing is typically done at diagnosis, after 1-2 months of treatment, and at the end of therapy.
- Laboratory Monitoring: Regular blood work to monitor for medication side effects, particularly liver enzymes with itraconazole and kidney function with amphotericin B.
- Imaging Studies: Repeat thoracic radiographs to monitor resolution of lung lesions.
- Ophthalmic Exams: For dogs with eye involvement, regular monitoring by a veterinary ophthalmologist.
- Treatment Duration Determination: Medication should continue for at least 1 month beyond clinical resolution and until antigen levels are negative or significantly decreased.
- Post-Treatment Monitoring: Regular check-ups for several months after treatment completion to watch for relapse.
Relapse occurs in approximately 20% of cases, typically within 6 months of discontinuing treatment. Dogs that relapse usually respond to a second course of antifungal therapy, though treatment duration is often longer. The most important factors for successful outcomes are early diagnosis, appropriate antifungal therapy, and completion of the full treatment course.
Treatment Considerations
Requires intensive, long-term management:
High Management
Treatment involves prolonged medication administration, regular monitoring, and significant financial commitment. Side effects require careful management.
Prognosis and Outcome
Guarded but Improvable with Treatment
70-75% Survival Rate
With appropriate treatment, most dogs survive. Neurological involvement carries the worst prognosis. Early treatment improves outcomes significantly.
When to Seek Veterinary Care
Contact your veterinarian immediately if your dog shows any of the following, especially if you live in or have visited an endemic area:
- Persistent cough or difficulty breathing
- Unexplained skin lesions, especially draining tracts
- Eye inflammation, cloudiness, or vision changes
- Lethargy, depression, or loss of appetite lasting more than 2-3 days
- Fever of unknown origin
- Lameness or swelling of limbs
- Seizures or other neurological symptoms
- Rapid weight loss
With appropriate and timely treatment, the prognosis for blastomycosis has improved significantly. However, the disease remains serious and requires committed, long-term management for successful outcomes.
Prevention Strategies
Preventing blastomycosis exposure is challenging but represents the only effective approach since no vaccine is available. A comprehensive prevention strategy focuses on minimizing environmental exposure in endemic areas.
Environmental Management
| Prevention Method | Implementation | Effectiveness |
|---|---|---|
| Avoid High-Risk Areas | Limit access to waterways, wooded areas, and construction sites in endemic regions | Most effective strategy; eliminates exposure risk |
| Leash Control | Keep dogs on leash in endemic areas to prevent digging and exploration of high-risk spots | Highly effective; prevents direct contact with soil |
| Yard Management | Remove organic debris, improve drainage, and limit soil exposure in yards | Moderately effective; reduces but doesn't eliminate risk |
| Avoid Soil Disturbance | Prevent digging and limit activities that aerosolize soil | Important for reducing inhalation exposure |
Practical Prevention Measures
- Awareness of Endemic Areas: Know the blastomycosis risk in your region and areas you visit
- Limit Outdoor Exposure: Especially after rain or in late summer/fall when risk may be higher
- Avoid Specific Locations: Be particularly cautious near riverbanks, lakeshores, and beaver dams
- Home Environment: Keep yards well-maintained with minimal exposed soil
- Education: Ensure all family members understand blastomycosis risks and prevention
- Early Detection: Know the symptoms and seek prompt veterinary care if they appear
- Regular Veterinary Care: Maintain routine health checks for early problem detection
Additional Prevention Considerations
- Travel Awareness: Be cautious when traveling with dogs to endemic areas
- New Home Considerations: Research blastomycosis risk when moving to new areas
- Construction Awareness: Be extra vigilant during local construction projects that disturb soil
- Multi-Dog Households: If one dog is diagnosed, monitor others closely for symptoms
- No Effective Vaccine: Understand that no blastomycosis vaccine is currently available
- Realistic Expectations: Recognize that complete prevention may not be possible in endemic areas
Special Considerations for High-Risk Situations
Extra precautions are needed for dogs with increased susceptibility or in situations of known high exposure. Hunting dogs and sporting breeds in endemic areas have particularly high risk and may benefit from more restrictive management. Dogs with compromised immune systems should have limited outdoor exposure in endemic regions. In multi-dog households where one dog has been diagnosed, other dogs should be monitored closely for symptoms, as they likely shared the same environmental exposure. While complete avoidance of endemic areas is the only certain prevention, this is often impractical. A balanced approach that minimizes high-risk exposures while maintaining quality of life is typically the most reasonable strategy.
Outbreak Management
While blastomycosis doesn't cause outbreaks in the traditional sense, multiple cases can occur from the same environmental source:
Prevention remains challenging due to the unpredictable nature of Blastomyces in the environment. The most practical approach involves awareness of risk, minimizing exposure where possible, and early detection and treatment when infection occurs.
Human Risk and Zoonotic Potential
Blastomycosis has significant zoonotic potential as it can infect both animals and humans, but direct transmission between species does not occur. Understanding the actual risks is important for appropriate precautions.
Zoonotic Transmission Risk
- No Direct Transmission: Infected dogs cannot transmit blastomycosis to humans or other animals
- Common Environmental Source: Both humans and dogs acquire infection from the same environmental sources
- Sentinel Value: Dogs often serve as sentinels for human exposure risk in an area
- Similar Susceptibility: Humans and dogs have similar susceptibility to infection
- Parallel Diagnosis: Human and animal cases in same household suggest common environmental exposure
Human Blastomycosis Infection
Human blastomycosis shares many characteristics with the canine disease:
- Acquisition: Humans acquire blastomycosis the same way dogs do - by inhaling spores from contaminated environments.
- Clinical Presentation: Similar to dogs, humans typically develop respiratory symptoms initially, with potential dissemination to skin, bones, and other organs.
- Diagnosis: Similar diagnostic approaches are used, including culture, histopathology, and antigen testing.
- Treatment: Humans are typically treated with similar antifungal medications, though specific drugs and durations may differ.
- Risk Factors: Outdoor occupations or activities in endemic areas increase human risk, similar to dogs with outdoor exposure.
- Mortality Rate: Approximately 5-10% in humans with appropriate treatment, similar to dogs.
The most important difference is that humans typically seek medical attention earlier in the disease course, while dogs may have more advanced disease at diagnosis. Additionally, children and immunocompromised individuals may be at higher risk for severe disease, similar to puppies and immunocompromised dogs.
Protective Measures for Humans
- Environmental Awareness: Know the blastomycosis risk in your area and areas you visit
- Protective Equipment: Wear masks during activities that disturb soil in endemic areas
- Avoid High-Risk Activities: Limit time spent in areas with known blastomycosis risk
- Early Medical Attention: Seek prompt medical care for persistent respiratory symptoms if you live in or have visited endemic areas
- Pet as Sentinel: If your dog is diagnosed with blastomycosis, be aware that you may have been exposed to the same environmental source
- Education: Ensure all family members understand blastomycosis risks and symptoms
- No Isolation Needed: Understand that infected pets do not need to be isolated from family members
Public Health Significance
Dogs serve as important sentinels for human blastomycosis risk. Because dogs typically spend more time outdoors and have closer contact with soil, they often develop clinical signs before humans in the same household or area. When a dog is diagnosed with blastomycosis, it should alert healthcare providers to the possibility of human cases from the same environmental source. However, it's important to maintain perspective - the overall risk to humans in endemic areas remains relatively low. Simple precautions like avoiding obvious soil disturbance and being aware of symptoms can significantly reduce risk while allowing normal outdoor activities.
Despite the zoonotic potential, the risk can be effectively managed with proper precautions. The benefits of pet ownership and outdoor activities generally far outweigh the blastomycosis risk when appropriate awareness and precautions are maintained.
Frequently Asked Questions
Yes, blastomycosis can be fatal to dogs, especially if left untreated. The mortality rate for untreated blastomycosis approaches 100%. However, with appropriate and timely treatment, survival rates of 70-75% can be achieved. Factors that worsen prognosis include:
- Severe respiratory involvement: Dogs with significant lung disease or respiratory distress
- Neurological involvement: The presence of brain or spinal cord infection carries the worst prognosis
- Disseminated disease: Widespread infection affecting multiple organ systems
- Treatment delay: The longer the disease progresses before treatment, the worse the outcome
- Concurrent health issues: Dogs with other serious medical conditions
Even with successful treatment, some dogs may have permanent damage to affected organs, particularly the eyes. Early diagnosis and appropriate treatment are the most important factors for survival.
No, you cannot get blastomycosis directly from your infected dog. The disease is not contagious between animals or from animals to humans. Here's why:
- Different Fungal Forms: The infectious form exists only in the environment as mold spores. In an infected animal, the fungus transforms into a yeast form that is not airborne or contagious.
- No Direct Transmission: There are no documented cases of blastomycosis transmission from dogs to humans or between dogs.
- Common Source Exposure: If both you and your dog develop blastomycosis, it means you were both exposed to the same environmental source, not that one infected the other.
However, if your dog is diagnosed with blastomycosis, it should serve as a warning that you may have been exposed to the same environmental source. You should monitor your own health and seek medical attention if you develop compatible symptoms, especially respiratory issues. There is no need to isolate your dog from family members during treatment.
Blastomycosis treatment is prolonged, typically lasting several months. The specific duration depends on several factors:
- Standard Treatment: Most dogs require 60-90 days of antifungal medication as a minimum.
- Severe Cases: Dogs with extensive disease, particularly neurological involvement, may require 4-6 months or longer.
- Treatment Monitoring: Medication should continue for at least 1 month beyond clinical resolution of symptoms and until antigen levels normalize.
- Relapse Cases: Dogs that relapse typically require longer treatment courses for the second round.
The lengthy treatment is necessary because antifungal medications typically only stop the fungus from growing rather than killing it outright. The dog's immune system must then eliminate the remaining organisms. Premature discontinuation of medication is the most common cause of treatment failure and relapse. Regular monitoring through physical exams, laboratory tests, and antigen levels helps determine the appropriate treatment duration for each individual dog.
No, there is currently no commercially available vaccine for blastomycosis in dogs or humans. Several factors contribute to the lack of a vaccine:
- Scientific Challenges: Developing effective vaccines against fungal pathogens has proven difficult due to the complex nature of fungal organisms and the immune response they elicit.
- Economic Considerations: The relatively limited market for a blastomycosis vaccine (primarily dogs in specific geographic regions) may not justify the significant development costs.
- Research Status: While research continues, no promising vaccine candidate has reached commercial availability.
- Alternative Approaches: Prevention currently focuses on avoiding exposure rather than vaccination.
Without a vaccine, prevention relies on environmental management and awareness:
- Avoiding known high-risk areas, particularly those with moist soil near waterways
- Keeping dogs on leash in endemic regions to prevent digging and exploration of high-risk spots
- Being aware of blastomycosis risk when traveling to endemic areas
- Early recognition of symptoms and prompt veterinary care
Research into blastomycosis vaccines continues, but no commercially available product is expected in the near future.
Yes, blastomycosis can recur after treatment, with relapse rates of approximately 20%. Several factors influence relapse risk:
- Inadequate Treatment Duration: The most common cause of relapse is premature discontinuation of medication.
- Severity of Initial Infection: Dogs with more widespread disease may have higher relapse rates.
- Drug Selection: Some antifungal medications may be more associated with relapse than others.
- Immune Status: Immunocompromised dogs may be more prone to relapse.
- Re-exposure: In rare cases, dogs may become reinfected from the environment after successful treatment.
Relapse typically occurs within 6 months of discontinuing treatment, though it can happen later. Signs of relapse are similar to the initial infection and may include:
- Return of respiratory symptoms
- Reappearance of skin lesions
- Lethargy and decreased appetite
- Fever
- Weight loss
Dogs that relapse usually respond to a second course of antifungal therapy, though treatment duration is often longer. Regular post-treatment monitoring helps detect relapse early when it's most treatable.
Routine testing of healthy dogs for blastomycosis is generally not recommended for several reasons:
- No Screening Test: There is no simple, reliable screening test for blastomycosis in asymptomatic dogs.
- Antibody Tests Unreliable: Antibody tests have poor sensitivity and specificity for screening purposes.
- Antigen Tests: Urine antigen tests are highly sensitive for active disease but not designed for screening asymptomatic animals.
- Cost Considerations: Routine testing of healthy dogs is not cost-effective.
- Geographic Limitations: Testing is only relevant in endemic areas.
Testing may be considered in specific situations:
- If a dog has known high-risk exposure (e.g., known point source exposure)
- In multi-dog households where one dog has been diagnosed
- Before starting immunosuppressive therapy in high-risk areas
- If a dog develops compatible symptoms
For most pet dogs, the best approach is awareness of blastomycosis risk in your area, knowledge of the symptoms, and prompt veterinary attention if symptoms develop. Consult with your veterinarian about whether testing might be appropriate for your specific situation.
Bottom Line: Protecting Your Dog from Blastomycosis
Blastomycosis is a serious systemic fungal infection caused by Blastomyces dermatitidis that can affect multiple organ systems in dogs, with respiratory, skin, and ocular manifestations being most common. The key to protection lies in comprehensive prevention including awareness of endemic areas, minimizing environmental exposure, and avoiding high-risk activities. If your dog shows symptoms like persistent cough, unexplained skin lesions, eye inflammation, or systemic signs—particularly with a history of exposure to endemic regions—consult your veterinarian immediately for appropriate testing. Diagnosis typically involves a combination of antigen testing, cytology, and clinical evaluation. Treatment requires prolonged courses of specific antifungal medications, with itraconazole being the treatment of choice for most cases. Remember that blastomycosis is not contagious between animals or to humans—both acquire infection from the same environmental sources. Most importantly, recognize that with early diagnosis and appropriate treatment, most dogs can survive this serious infection, though treatment is lengthy and requires committed follow-up. With comprehensive knowledge, appropriate veterinary care, and consistent prevention practices, you can effectively address blastomycosis concerns while maintaining the health of your canine companion.
References and Further Readings
Explore More Stories
About the Author
